Karolinska University Hospital
Stockholm, SE-14186, Sweden
NCT Number: NCT03301935
Prospective cohort study including 150 patients with pre-excitation on ECG referred to our clinic for risk assessment. There will be equal numbers of symptomatic and asymptomatic patients included in the study. Each patient will perform an exercise stress test on bicycle before an invasive electrophysiological test. The purpose of this study is to compare exercise stress testing on bicycle to an invasive electrophysiological study, regarding risk assessment of patients with pre-excitation. The electrophysiology study is set as reference.
Looking for future studies?
Notify MeAll sexes
Observational
Stockholm, SE-14186, Sweden
Hypothesis:
The sensitivity and specificity for exercise stress test (bicycle) is low in identifying patients with benign accessory pathways and cannot replace an invasive electrophysiological study in risk assessment of symptomatic and asymptomatic patients with pre-excitation. Invasive electrophysiological assessment should be recommended for all patients with pre-excitation despite symptoms or documented arrhythmia.
Methods:
Prospective cohort study including 150 patients with pre-excitation on ECG referred to our clinic for risk assessment. There will be equal numbers of symptomatic and asymptomatic patients included in the study. Each patient will perform an exercise stress test on bicycle before an invasive electrophysiological test. The purpose of this study is to compare exercise stress testing on bicycle to an invasive electrophysiological study, regarding risk assessment of patients with pre-excitation. The electrophysiology study is set as reference.
A. Instruments and methods for analysis:
This procedure is set as reference in identifying potentially dangerous accessory pathways.
Programmed stimulation for risk assessment in patients with pre-excitation/accessory pathways:
Retrograde APERP and AVNERP
Statistical analysis: Sensitivity, specificity, positive predictive value and negative predictive value of exercise stress test will be assessed, using the electrophysiological study as a reference standard. A true positive and a false negative will be defined, respectively, as the persistence and the disappearance of pre-excitation in the symptomatic and asymptomatic group. A true negative and a false positive will be defined, respectively, as the disappearance and the persistence of pre-excitation in the symptomatic and asymptomatic group. Moreover, we will consider the shortest value between the minimum RR interval during atrial fibrillation and accessory pathway anterograde effective refractory period (APERP) in each patient and look for the value that could be predicted by noninvasive tests with the best combination of sensitivity, specificity, positive and negative predictive value.
Chi Square statistics will be used in comparing categorical data such as inducibility and tachycardia cycle length.
B. Calculation of power: With the planned number of patients, 150, a 10% difference should be detected with a power of 80% at α 0,1.
C. Expected results: We expect exercise testing to have high sensitivity, but low specificity and a low positive predictive value.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each patient will perform an exercise stress test on bicycle before an invasive electrophysiological test. Both examinations will be performed according to current Clinical practice.
Time frame: Approximately 1 year from inclusion to 6 months follow-up.
Number of potentially dangerous pathways (i.e APERP <250 ms) identified by exercise stress test compared to the invasive electrophysiological test in the symptomatic- and asymptomatic Group.
Karolinska University Hospital
Other
Acronym: RASAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06349109
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Ankara, Turkey (Türkiye)
View Trial DetailsNCT00251121
Arrhythmias, Cardiac, Atrial Fibrillation
Skien, Telemark, Norway
View Trial DetailsNCT04361006
Accessory Pathway, Arrhythmias, Cardiac
São Paulo, Brazil
View Trial DetailsNCT07435181
Arrhythmias, Cardiac, Atrioventricular Reentrant Tachycardias
View Trial Details